News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Conference News ESC 2018 CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients Todd Neale August 25, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017
News Conference News ESC 2017 Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1 Michael O'Riordan September 05, 2017
News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
News Conference News ESC 2017 Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen L.A. McKeown August 30, 2017
News Conference News ESC 2017 Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed Michael O'Riordan August 29, 2017
News Conference News ESC 2017 PURE Investigators: Rethink Diet Guidance to Plug More Fats, Fewer Carbs Shelley Wood August 29, 2017
News Conference News ESC 2017 Less Is More? Health Benefits of Fruits, Vegetables, and Legumes Seen at Lower Intake Levels Michael O'Riordan August 29, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Conference News ESC 2017 Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women Michael O'Riordan August 26, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Opinion Editor's Corner ESC 2016 My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance Shelley Wood September 08, 2016